TILS.L Regulatory News (TILS)

29 Jun 2007 07:02

ReGen Therapeutics PLC29 June 2007 ReGen Therapeutics Plc ("ReGen" or "the Company") TOTAL VOTING RIGHTS In conformity with the Transparency Directive's chapter 5 (DTR 5.6.1), the Boardof ReGen Therapeutics Plc (the 'Company') announces the following: As at the date of this announcement, the Company's issued share capital consistsof 1,025,887,710 Ordinary Shares with a nominal value of 0.1 pence each, withvoting rights ('Ordinary Shares'). The Company does not hold any Ordinary Shares in Treasury. Therefore the total number of Ordinary Shares in the Company with voting rightsis 1,025,887,710. The above figure of 1,025,887,710 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they will determineif they are required to notify their interest in, or a change to their interestin, the share capital of the Company. - Ends - For further information please contact: Percy LomaxReGen TherapeuticsTel. 020 7153 4920 Andrew MarshallGreycoat CommunicationsTel. 020 7960 6007 Andrew Baker / Cecil Jordaan / Rory CreedonHB CorporateTel. 020 7510 8561 This information is provided by RNS The company news service from the London Stock Exchange